4Van Moorsel CJ, Pinedo HM, Veerman G, et al. Mechanisms of synergism between cisplatin and gemcitabine in overian and non-small cell lung cancer cell lines [ J ]. Br J Cancer,1999,80(7 ) :981. 被引量：1
1[1]Moorsel CJAV, Veeman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine. Semin Oncol, 1997,24(2 Suppl 17) :17 被引量：1
2[2]Sandler A, Nemunaitis J, Denham C, et al. Phase Ⅲ trial ofgemcitabine plus cisplatin versus cisplatin alone in patients with locally advance or metastatic non- small cell lung cancer. J Clin Oncol, 2000, 18 (1) :122 被引量：1
3[3]Crino L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advance non -small cell lung cancer: Aphase Ⅱ study. JClinOncol, 1997, 15 (1) :297 被引量：1
4[1]Shord SS, Faucette SR, Gillenwater HH, et al. Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer. Cancer Chemother Pharmacol, 2003, 51: 328 被引量：1
5[2]Highlights from the 10th World Conference on Lung Cancer.Vancouver, British Columbia, Canada, August 10～ 14,2003. Clin Lung Cancer, 2003, 5:142 被引量：1
6[3]Bretti S, Manzin E, Loddo C, et al. Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase Ⅱ study. Anticancer Res, 2002, 22:3039 被引量：1
7[4]Migliorino MR, De Marinis F, Nelli F, et al. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for stage Ⅲ non-small cell lung cancer. Lung Cancer, 2002,35:319 被引量：1
8[5]Jassem J, Krzakowski M, Roszkowski K, et al. A phase Ⅱstudy of gemcitabine plus cisplatin in patients with advanced nonsmall cell lung cancer: Clinical outcomes and quality of life.Lung Cancer, 2002, 35:73 被引量：1
9[6]Thongprasert S, Chewaskulyong B, Pothirat C. Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer. J Med Assoc Thai, 2001, 84:397 被引量：1
10[7]Kusaba H, Tamura T, Shimoyama T, et al. Phase Ⅰ/Ⅱstudy of 3-week cycle cisplatin-gemcitabine in advanced nonsmall cell lung cancer. Jpn J Clin Oncol, 2002, 32:43 被引量：1
